Tag Archive for Mannatech

Mannatech Launches the “Love Your Liver 21-Day Reset” Across Global Markets

Community-powered wellness program driven by glycan technology
FLOWER MOUND, TX — December 9, 2025 — Mannatech, a global innovator in glycan-based nutrition and integrative wellness solutions, today announced the expansion of its Love Your Liver 21-Day Reset, a structured health-support program now available across the USA, Canada, Europe, Latin America, and Australia.
The Reset has generated strong engagement across Mannatech’s global wellness communities, with participants sharing their experiences on WhatsApp, Facebook, and regional forums. The initiative combines science-backed glycan supplementation with community-driven support and accountability.
About the 21-Day Reset
The Love Your Liver 21-Day Reset is a guided nutritional and lifestyle program designed to support healthy liver function, digestive balance, cellular communication, energy, and overall well-being.* The program integrates a clean, structured food plan with Mannatech supplements, including:

Ambrotose® products for glycan support*
GI-ProBalance® slimsticks for microbiome and digestive support*
TruHealth™ Cleanse for gentle detoxification support*
TruHealth™ Shakes and TruHealth™ Satiety capsules for sustained energy and balanced appetite*

Participants receive a step-by-step guide, recipes, shopping lists, and access to accountability groups in markets worldwide, with optional plant-based or protein-based pathways for Days 11–21.

Community Momentum
The Reset is resonating with wellness-focused consumers seeking simple daily structure, clean whole-food guidance, science-backed nutrition, and an encouraging community. Leadership from Mannatech executives and independent

Read more...

Mannatech Reports Financial Results for Third Quarter 2025

Mannatech Announces Q3 2025 Results Highlighting Margin Improvements and Stronger Profitability
Mannatech, Incorporated has released its financial results for the third quarter of 2025, reporting notable gains in margins and profitability, with Asia-Pacific continuing to be the strongest region for the company. Gross profit as a percentage of net sales rose to 76.4%, supported by pricing adjustments, efficient inventory management, and the timing of promotional activities.
Operational performance also strengthened. Income from operations increased to $2.0 million, more than double the prior-year period, while net income reached $1.9 million, or $1.01 per diluted share, compared to a loss in Q3 2024.
Asia-Pacific remained the company’s leading region, generating $18.8 million, or more than 64% of total quarterly revenue, followed by $7.9 million from the Americas.
Mannatech reported 119,000 active associate and preferred customer positions, with Asia-Pacific continuing to be the most consistent region for ongoing activity.
Net sales for the quarter totaled $29.2 million, compared to $31.7 million in the same period of 2024 — a change the company attributes to slowing demand in certain regions.
Importantly, the company noted that Q3 sales exceeded the first two quarters of 2025, indicating improved momentum as the year progressed.
Mannatech closed the quarter with $7.1 million in cash and cash

Read more...

Colombian Power Couple Fabián Ríos & Yuli Ferreira to Headline MannaFest 2025

Colombian Power Couple Fabián Ríos and Yuli Ferreira to Headline MannaFest 2025—A Global Celebration of Wellness, Purpose, and Possibility
Mannatech, a global pioneer in Glycan Replenishment Therapy (GRT) and purpose-driven wellness, is thrilled to announce that Fabián Ríos, internationally acclaimed Colombian actor and humanitarian, will be a featured speaker at MannaFest 2025, taking place April 22–24 at the Texas Motor Speedway.
Fabián will be joined by his wife, actress and wellness influencer Yuli Ferreira, as they help ignite a movement of health, impact, and entrepreneurship.
Fabián & Yuli at Billboard Latin Music Awards 
With millions of fans across Latin America and the United States, Fabián Ríos brings star power, heartfelt conviction, and business acumen to the stage. Formerly a Diamond-ranked Network Marketing leader, Fabián is uniquely positioned to speak to the life-changing potential of the direct sales model. His session at MannaFest 2025 will energize aspiring entrepreneurs to build purpose-driven businesses with Mannatech’s transformative product line.
Beyond his success in the entertainment industry and business, Fabián is being honored for his lifelong passion for giving back.
At the M5M Foundation Gala, he will be officially named Celebrity Global Ambassador of the M5M Foundation, Mannatech’s nonprofit organization committed to improving the lives of malnourished children worldwide. As keynote

Read more...

La Pareja Poderosa de Colombia, Fabián Ríos y Yuli Ferreira, Encabezará MannaFest 2025

La Pareja Poderosa de Colombia, Fabián Ríos y Yuli Ferreira, Encabezará MannaFest 2025—Una Celebración Global de Bienestar, Propósito y Posibilidades
Mannatech, pionera global en Terapia de Reposición de Glicanos (GRT, por sus siglas en inglés) y bienestar con propósito, se complace en anunciar que Fabián Ríos, actor colombiano de renombre internacional y humanitario, será uno de los oradores principales en MannaFest 2025, que se llevará a cabo del 22 al 24 de abril en el Texas Motor Speedway.
Lo acompañará su esposa, la actriz e influencer de bienestar Yuli Ferreira, para encender un movimiento de salud, impacto y emprendimiento.
Fabián y Yuli en evento Los Premios Billboard de la Música Latina. Miami, Florida.
Con millones de seguidores en América Latina y Estados Unidos, Fabián Ríos aporta carisma, convicción genuina y visión empresarial al escenario. Exlíder de Marketing Multinivel con rango Diamante, Fabián tiene una perspectiva única sobre el poder transformador del modelo de venta directa. Su participación en MannaFest 2025 inspirará a emprendedores a construir negocios con propósito utilizando la línea de productos transformadores de Mannatech.
Más allá de su éxito en el entretenimiento y los negocios, Fabián será honrado por su compromiso de toda la vida con el servicio a los demás. En la

Read more...

Mannatech Shares Q4 and 2024 Year-End Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced its fourth quarter and full-year 2024 financial results.
Highlights include a return to profitability, improved operating results, margin expansion, and enhanced cost efficiency, underscoring the company’s resilience and forward-looking strength.
Fourth Quarter 2024 Financial Highlights:

Return to Profitability: Net income of $2.3 million (or $1.20 per diluted share) in Q4 2024, a strong turnaround from a net loss of $1.8 million (or $0.94 per share) in Q4 2023.
Higher Margins: Gross profit margin expanded to 80.5% in Q4 2024, up from 75.4% in the prior-year quarter, reflecting improved operational efficiency and cost management.
Improved Operating Results: Operating income of $0.9 million, compared to an operating loss of $0.9 million in Q4 2023, driven by disciplined expense control and productivity gains.
Cost Efficiency: Selling and administrative expenses in Q4 were reduced by $1.7 million year-over-year, through streamlined operations and lower marketing, payroll, and travel costs.

Full-Year 2024 Financial Highlights:

Annual Profit Growth: Net income of $2.5 million (or $1.32 per diluted share) for full-year 2024, a significant improvement from a net loss of $2.2 million (or $1.20 per share) in 2023.
Positive Operating Income: Operating income of $1.4 million for 2024, compared to an operating loss of $1.0 million

Read more...

Mannatech Reports Revenue Of $31.7 Million For Q3 – 2024

Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “Company”), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024.
Landen Fredrick, President and CEO, noted that,

“Although the third quarter of 2024 provided our highest revenue quarter in 2024, we continued to battle demand weakness in the third quarter across our global operations, with the most significant impact in the Asia/Pacific region due to ongoing economic challenges.
Despite anticipating continued economic difficulties for the rest of 2024, we are committed to increasing our revenue by growing our team of sales associates and expanding our base of preferred customers, all while keeping costs under strict cost controls.”

Third Quarter Highlights
Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to slowing demand in Asia due to weakened economic conditions,

Read more...

Mannatech Q2 Revenue 2024 Down 14.9% To $27.7 Million

Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “Company”), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024.
Second Quarter Highlights

Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%.

On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally due to supply chain constraints, items on back order, and some weakening of economic conditions in Asia.
Gross profit as a percentage of net sales decreased to 77.1% for three months ended June 30, 2024, as compared to 78.5% for the same period in 2023, some of the increase in costs were related to increased freight costs related to back ordered items and running some sales promotions on products thereby reducing our margin.

Commission expenses for the three months ended June 30, 2024 decreased by 12.5%, or $1.6 million, to $11.1 million, as compared to $12.7

Read more...

Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

Mannatech, Incorporated recently announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated.
James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron, Guided Therapeutics, Aeterna Zentaris, and Tri-source Pharma.
Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and drug development agreements, and he has advised companies with complex restructurings, mergers, acquisitions, capital market transactions, and system implementations. Mr. Clavijo served as an Officer in the U.S. Army for 13 years in active and reserve duty.
He holds a BA in Chemistry (PreMed) from the University of Florida, a BA in Accounting from the University of Nebraska, and a master’s in accounting from Florida International University. Mr. Clavijo was licensed as a CPA in Florida from 2000-2011.
As previously announced, Landen Fredrick, the Company’s Chief Executive Officer, has been serving as interim CFO for the Company since January 2024. Mr. Fredrick will relinquish the responsibilities to Mr. Clavijo as he focuses on oversight of the senior executive team and the team of general managers over our international markets, driving operational

Read more...

Mannatech Q1 Revenue 2024 Down 13.8% To $29.4 Million

First Quarter Highlights
Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%.
On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compared to the same period in 2023. The decline in revenues was principally in our Asia/Pacific region reflecting reduced recruiting of sales associates and preferred customers along with continued weak economic conditions.^

Gross profit as a percentage of net sales increased to 78.6% for three months ended March 31, 2024, as compared to 78.3% for the same period in 2023, largely due to reduced costs of freight and shipping and other supply chain initiatives.

Income from operations was $0.8 million for the three months ended March 31, 2024 as compared to $0.7 million in the same period last year. On a Constant dollar basis (see Non-GAAP Measures, below), income from operations was unfavorably affected by $0.3 million due to foreign exchange. Higher gross profit margins coupled with lower selling and administrative expenses resulting from cost reductions, more than offset the

Read more...

Mannatech Expanding With Thailand Office

Mannatech, Incorporated (NASDAQ: MTEX), a leading global health and wellness company committed to transforming lives through Glycan technology, is thrilled to announce a significant milestone in its expansion efforts. With a steadfast commitment to empowering individuals and communities through innovative health solutions, Mannatech is excited to announce its continued expansion into the ASEAN region, with the official launch into the Thailand market.
This opening will bring Mannatech’s global presence to 26 markets.
Landen Fredrick, President and CEO, said:

“Existing and future Mannatech Associates eagerly anticipate the official launch in Thailand on June 17, 2024. During the soft opening, individuals will be able to register as Mannatech Associates.
Additionally, we will launch Luminovation™ skin care, our premier K-Beauty line. This marks the initial step towards establishing a robust presence in the region, laying the groundwork for the future. This new market launch signifies a momentous occasion for Mannatech and its dedicated Associates.
Mannatech’s expansion into Thailand is our first new market in several years and provides an exciting opportunity to introduce our products to a new country and culture. The opening team, led by Roh Jae-hong, Mannatech Korea’s general manager, has conducted extensive market research, and worked tirelessly to prepare for this launch. We are

Read more...